Total Payments
$3,341
2021 Payments
$720.06
Companies
27
Transactions
202
Medicare Patients
3,294
Medicare Billing
$299,483
Payment Breakdown by Category
Food & Beverage$3,341 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,341 | 202 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $577.24 | 30 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $324.50 | 18 | $0 (2021) |
| AbbVie Inc. | $247.36 | 15 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $233.79 | 20 | $0 (2021) |
| PFIZER INC. | $231.10 | 16 | $0 (2021) |
| GlaxoSmithKline, LLC. | $220.72 | 13 | $0 (2021) |
| Novo Nordisk Inc | $201.96 | 13 | $0 (2021) |
| Lilly USA, LLC | $164.98 | 11 | $0 (2021) |
| Amgen Inc. | $144.48 | 9 | $0 (2019) |
| SANOFI PASTEUR INC. | $117.51 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $720.06 | 41 | AbbVie Inc. ($122.71) |
| 2020 | $337.54 | 21 | Novo Nordisk Inc ($66.96) |
| 2019 | $616.36 | 35 | AstraZeneca Pharmaceuticals LP ($175.47) |
| 2018 | $717.05 | 46 | AstraZeneca Pharmaceuticals LP ($153.41) |
| 2017 | $950.12 | 59 | AstraZeneca Pharmaceuticals LP ($124.86) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Diabetes Care | ||||||
| 12/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 11/18/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/17/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 11/01/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiovascular | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX QUADRIVALENT | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: VACCINES | ||||||
| 09/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Cardiovascular | ||||||
| 09/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
| 07/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: GASTROINTESTINAL | ||||||
| 06/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Vaccines | ||||||
| 05/13/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular | ||||||
| 05/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 14 | 998 | 1,295 | $266,883 | $111,089 |
| 2021 | 19 | 1,332 | 1,683 | $383,614 | $113,978 |
| 2020 | 11 | 964 | 1,192 | $272,660 | $74,416 |
Total Patients
3,294
Total Services
4,170
Medicare Billing
$299,483
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 567 | $150,529 | $52,644 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 187 | 187 | $53,482 | $28,039 | 52.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 104 | 104 | $12,896 | $7,166 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 77 | $14,200 | $4,887 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 32 | $11,296 | $4,029 | 35.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 98 | 98 | $6,370 | $3,399 | 53.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $4,253 | $3,076 | 72.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 54 | 54 | $2,700 | $2,472 | 91.6% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 48 | 48 | $2,400 | $2,221 | 92.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $3,204 | $1,710 | 53.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $1,300 | $697.65 | 53.7% |
| 90471 | Administration of vaccine | Office | 2022 | 33 | 33 | $2,145 | $360.63 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 31 | $1,860 | $307.76 | 16.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 19 | 19 | $247.00 | $81.65 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 274 | 560 | $170,240 | $36,568 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 206 | 206 | $66,126 | $31,570 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 223 | 285 | $58,710 | $12,245 | 20.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 90 | 90 | $13,713 | $5,873 | 42.8% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 74 | 74 | $7,400 | $3,485 | 47.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 27 | 27 | $5,825 | $3,376 | 58.0% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 50 | 50 | $7,600 | $3,263 | 42.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 29 | $11,745 | $3,149 | 26.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 144 | 144 | $10,512 | $2,889 | 27.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 13 | 14 | $6,496 | $2,685 | 41.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 12 | 12 | $4,932 | $2,655 | 53.8% |
About Dr. Robert Maggin, MD
Dr. Robert Maggin, MD is a Internal Medicine healthcare provider based in Laurel, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255322574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Maggin, MD has received a total of $3,341 in payments from pharmaceutical and medical device companies, with $720.06 received in 2021. These payments were reported across 202 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,341).
As a Medicare-enrolled provider, Maggin has provided services to 3,294 Medicare beneficiaries, totaling 4,170 services with total Medicare billing of $299,483. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Laurel, MD
- Active Since 11/04/2005
- Last Updated 07/09/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255322574
Products in Payments
- FARXIGA (Drug) $260.43
- XIGDUO (Drug) $239.80
- TRADJENTA (Drug) $206.29
- JARDIANCE (Drug) $187.87
- SHINGRIX (Biological) $151.76
- UBRELVY (Drug) $148.48
- Prolia (Biological) $115.34
- JANUVIA (Drug) $112.98
- Ozempic (Drug) $111.74
- CYCLOSET (Drug) $97.54
- Vascepa (Drug) $97.25
- TRINTELLIX (Drug) $96.10
- Synthroid (Drug) $62.99
- PREVNAR - 13 (Biological) $60.14
- TRULICITY (Drug) $59.87
- SYMBICORT (Drug) $55.31
- CHANTIX (Drug) $53.08
- TOUJEO (Drug) $52.55
- KRYSTEXXA (Biological) $50.87
- FLUZONE HIGH-DOSE (Drug) $48.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Laurel
Willus Horne, M.d, M.D
Internal Medicine — Payments: $6,770
Internal Medicine $6,770
Dr. Timothy Mcclain, M.d, M.D
Internal Medicine — Payments: $6,372
Internal Medicine $6,372
Mark Norton, M.d, M.D
Internal Medicine — Payments: $6,264
Internal Medicine $6,264
Prema Siva, Md, MD
Internal Medicine — Payments: $3,655
Internal Medicine $3,655
Lalitha Tadikonda, Md, MD
Internal Medicine — Payments: $3,341
Internal Medicine $3,341
Dr. Bennett So, M.d, M.D
Internal Medicine — Payments: $3,242
Internal Medicine $3,242